Pharma & Biotech

Iovance Biotherapeutics is embarking on an ambitious worldwide expansion strategy, seeking regulatory clearances for its innovative cancer treatments across multiple...

Eli Lilly finds itself at the heart of a high-stakes legal confrontation that could jeopardize its most profitable revenue stream....

A prolonged regulatory standoff with U.S. health authorities has concluded favorably for Ocugen. The biopharmaceutical company announced that the Food...

Medical technology firm Zynex is confronting a severe strategic crisis, prompting a dramatic shift in direction for its patient monitoring...

Shares of Applied Therapeutics experienced a dramatic upswing on Tuesday, posting an impressive gain of over 11%. The stock reached...

The Danish pharmaceutical leader Novo Nordisk is confronting a perfect storm of adverse developments. A significant legal defeat in the...

Germany's transition to digital prescriptions is proving to be a powerful catalyst for Redcare Pharmacy, with the MDAX-listed company reporting...

The French vaccine developer Valneva finds itself at a pivotal moment, with its future prospects increasingly tied to the success...

Walgreens shareholders are navigating a complex landscape as the pharmacy giant completes its transition to private ownership while confronting substantial...

Johnson & Johnson is demonstrating remarkable momentum on dual fronts. The healthcare conglomerate's shares are approaching a fresh annual peak,...